ArticleTranslational vision science & technology2022

Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model.

William Schubert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.